Molecular Diagnostics

Automated Detection of Arm-Level Alterations for Individual Cancer Patients
Copy number alterations (CNAs) can be gains, losses, or loss of heterozygosity (LOH) of a chromosome segment. Based on the length of the altered segment, they are crudely classified as “focal alterations” and “arm-level alterations”. More...25 Sep 2021
Serum Levels of Thymidine Kinase Predict Disease Progression and Overall Survival of Metastatic Breast Cancer Patients
Blood serum levels of the enzyme thymidine kinase 1 (TK1) have been found to predict disease progression and overall survival of patients with metastatic hormone receptor-positive breast cancer (MBC). More...25 Sep 2021
Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections
CerTest Biotec (Zaragoza, Spain; www.certest.es) has joined the fight against multidrug resistant strains (MDR) bacterial infections by developing real-time PCR assays for the fast detection of genes or punctual mutations that confer resistance to antibiotics from both Gram-positive and Gram-negative pathogens. More...23 Sep 2021

Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes. More...22 Sep 2021

Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes. More...22 Sep 2021


Acute Lymphoblastic Leukemia Risk Linked to Genetically Mediated Increase in Lymphocytes
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. As an acute leukemia, ALL progresses rapidly and is typically fatal within weeks or months if left untreated. More...15 Sep 2021
In Other News
Biomarkers Found for COVID-19 MIS-C Condition in Children
Blood Biomarkers Predict Likelihood of Castleman Disease Treatment Response
Liquid Biopsy Assay Evaluated for Early Detection of Gastric Cancer
Genomics Approach Links ABO Blood Type to Inflammatory and Cardiovascular Diseases
Immune Cell Biomarker Predicts Response to Treatment with Checkpoint Inhibitor Drugs
Novel PCR Test Could Quickly Distinguish Breast Cancer from Benign Tumors
Molecular Characterization of Microbiota in Cerebrospinal Fluid Using WGA
Donor-Linked Biomarker Predicts Likelihood of Liver Transplant Success
Leptomeningeal Disease Diagnosed Using CSF Cell-Free DNA
Various Serum Vitamin D Biomarkers Compared for Sarcopenia
Sphingolipids Are Prognostic Biomarkers for African American SLE Patients with Cardiovascular Disease
CSF biomarkers Compared for Down Syndrome and Inherited Alzheimer’s
More Complete Genetic Screening Benefits Cardiovascular Disease Patients
A Novel Liquid Biopsy Spectroscopy Method for Early Detection of Brain Tumors
A Circulating Adipokine Is a Possible Biomarker for Severity of Systemic Sclerosis-Associated Interstitial Lung Disease
Lipid Metabolism Affects GBA-Associated Parkinson's Disease
Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes
Early T-Cell Precursor Lymphoblastic Lymphoma Characterized
Insulin Resistance and T2D Associated With Gut Microbial Diversity
Molecular Assays Compared For MRD Detection In B-ALL
Microbiome and Metabolic Features Tied to IBD Treatment Response
Genomic Test Aids in Determining Prostate Cancer Treatment Options
Advanced Sequencing Techniques Determine Cancer Genome Variants in Young Patients
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








